Mumps, or epidemic parotitis, is a viral infectious disease caused by the mumps virus of the Paramyxoviridae family. The disease is characterized by inflammation and swelling of the parotid salivary glands, often accompanied by fever, headache, and general weakness. The virus is transmitted by airborne droplets, and its incubation period can be from 16 to 18 days. Mumps is most common in childhood, but can also affect adults, causing serious complications such as orchitis, meningitis, and pancreatitis. Vaccination against mumps has significantly reduced the incidence of the disease in countries with high vaccination coverage, but cases are still reported.
History of the disease and interesting historical facts
The history of mumps goes back several centuries. The first mentions of the disease can be found in medical treatises of the 16th century, when doctors described epidemics accompanied by characteristic symptoms. Interesting fact: until the end of the 19th century, mumps was considered a “childhood disease” and its cases were not considered a serious illness. The spread of the mumps vaccine, developed in 1967, became a turning point in the fight against the disease, significantly reducing the incidence rate. Today, various cultural and social aspects, such as vaccine myths and mistrust of medical institutions, affect the level of vaccination, which in turn also affects the incidence of diseases.
Epidemiology
Mumps remains a public health concern worldwide. According to the World Health Organization (WHO), mumps incidence has decreased by 90% in countries with high vaccination coverage. However, outbreaks have been reported in countries with low vaccination coverage in recent years. For example, more than 4,000 cases of mumps were reported in the WHO European Region in 2019, three times more than in the previous year. Children aged 5 to 14 years are most susceptible to infection, but the number of cases among adults is gradually increasing. The connection with delayed vaccination and migration flows also aggravate the situation, creating conditions for the emergence of new outbreaks of the disease.
Genetic predisposition to this disease
It is currently known that genetic susceptibility to mumps is not defined, as is the case with many other viral infections. Studying the genes involved in the immune response to infection may provide clues to susceptibility. Some studies suggest that genetic variations in the HLA (human leukocyte antigen) system may influence the development of the clinical picture of the disease. However, more research is needed to clearly define how genetic factors may influence susceptibility to the virus.
Risk factors for the development of this disease
Among the main risk factors for the development of mumps, several groups can be distinguished:
- Unvaccinated or undervaccinated individuals.
- Contact with people infected with mumps.
- Being in closed or large gatherings (schools, kindergartens, public transport).
- Age (the most vulnerable are children from 5 to 14 years old).
- Reduced immunity or previous illnesses.
These factors, especially in conditions of close contact and insufficient vaccination, contribute to the emergence of outbreaks of the disease even in those countries where a high degree of control over it was previously achieved.
Diagnosis of this disease
Diagnosis of mumps is based on clinical examination and laboratory tests. The main symptoms of the disease include:
- Swelling and soreness of the parotid glands.
- Fever.
- Headache.
- General weakness and malaise.
Laboratory tests such as serologic tests for mumps virus-specific IgM and IgG antibodies can confirm the diagnosis. Radiologic examinations including ultrasound can help visualize inflammation of the salivary glands. Differential diagnosis with other diseases such as epidemic hemorrhagic parotitis, tonsillitis and other infectious diseases should be considered.
Treatment
Treatment of mumps is mainly symptomatic, as there is no specific antiviral therapy. The main measures include:
- Ensure rest and adequate fluid intake.
- Use of antipyretic drugs to reduce temperature.
- Using analgesics to relieve pain.
In complicated cases, hospitalization may be required, especially in cases of complications such as meningitis or orchitis. Surgical treatment may be necessary in cases of purulent processes in the salivary glands. The use of additional treatment methods such as physiotherapy may also be helpful in alleviating the patient's condition.
List of medications used to treat this disease
The main groups of drugs used to treat mumps are:
- Analgesics (paracetamol, ibuprofen) to relieve pain and fever.
- Antiviral drugs in cases of complications (if applicable).
- Antibiotics in the presence of bacterial complications.
It should be noted that the use of antibiotics is justified only for secondary infections, since mumps itself is a viral disease.
Disease monitoring
Monitoring of patients with mumps includes monitoring of symptoms and possible complications. The main stages of monitoring are:
- Regular assessment of general health.
- Monitoring the occurrence of complications (orchitis, meningitis, pancreatitis).
- The prognosis depends on the patient's age and health; in most cases, if there are no complications, a full recovery occurs.
The prognosis in children is usually favorable, but in adults, especially with concomitant diseases, serious complications are possible.
Age-related features of the disease
Mumps manifests itself differently depending on age. In children, the disease is usually milder, with typical symptoms of inflammation of the parotid glands. In adults, the disease can be more severe, with a high risk of complications such as orchitis or meningitis. Children under 5 years of age are generally less prone to more severe forms, but they may experience more discomfort if there is a plug in the salivary glands. Older people have a higher incidence of severe forms of mumps, which is associated with a weakened immune system.
Questions and Answers
- What are the main symptoms of mumps? The main symptoms include swelling of the parotid glands, fever, headache and general weakness.
- How is mumps transmitted? The mumps virus is transmitted by airborne droplets from an infected person to a healthy one.
- What prevention of mumps exists? The main prevention of mumps is vaccination, which is recommended in childhood.
- Can there be complications in adults? Yes, in adults, mumps can lead to serious complications such as orchitis and meningitis.
- How long is the incubation period for mumps? The incubation period for mumps is 16 to 18 days.
